Effectiveness of high-dose G-CSF (32 μg/kg) for stem cell mobilization after failure of chemotherapy plus standard dose G-CSF (10 μg/kg) for autologous stem cell transplantation.

被引：0
|
作者：
Voralia, M [1 ]
Nagy, T [1 ]
Trip, K [1 ]
Chen, C [1 ]
Keating, A [1 ]
Crump, M [1 ]
机构：
[1] Princess Margaret Hosp, Toronto, ON M4X 1K9, Canada
来源：
BLOOD | 2000年 / 96卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
766
引用
收藏
页码：178A / 178A
页数：1
相关论文
共 50 条
  • [21] Pegylated G-CSF after autologous hematopoietic stem cell transplantation
    Annaloro, C.
    Usardi, P.
    Della Volpe, A.
    Onida, F.
    Basilico, C.
    Deliliers, G. Lambertenghi
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 74 - 74
  • [22] Hematopoietic, Immune Recovery and Outcomes after Autologous Stem Cell Transplantation Following Plerixafor Plus G-CSF Versus Chemotherapy and G-CSF Based Mobilization in Pediatric Patients
    Choi, Jung Yoon
    Kang, Hyoung Jin
    Hong, Kyung Taek
    Hong, Che Ry
    Park, Kyung Duk
    Shin, Hee Young
    BLOOD, 2017, 130
  • [23] G-CSF Plus Preemptive Plerixafor Versus Cyclophosphamide Plus G-CSF for Autologous Stem Cell Mobilization in Multiple Myeloma: Effectiveness, Safety and Cost Analysis
    Antar, Ahmad
    Otrock, Zaher
    Kharfan-Dabaja, Mohamed
    Abou Ghaddara, Hussein
    Kreidieh, Nabila
    Mahfouz, Rami
    Bazarbachi, Ali
    BLOOD, 2014, 124 (21)
  • [24] Equivalent mobilization and collection of granulocytes for transfusion after administration of glycosylated G-CSF (3 μg/kg) plus dexamethasone versus glycosylated G-CSF (12 μg/kg) alone
    Heuft, HG
    Goudeva, L
    Sel, S
    Blasczyk, R
    TRANSFUSION, 2002, 42 (07) : 928 - 934
  • [25] Cost and Clinical Analysis of Autologous Hematopoietic Stem Cell Mobilization with G-CSF and Plerixafor Compared to G-CSF and Cyclophosphamide
    Shaughnessy, Paul
    Islas-Ohlmayer, Miguel
    Murphy, Julie
    Hougham, Maureen
    MacPherson, Jill
    Winkler, Kurt
    Silva, Matthew
    Steinberg, Michael
    Matous, Jeffrey
    Selvey, Sheryl
    Maris, Michael
    McSweeney, Peter A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (05) : 729 - 736
  • [26] Higher efficacy of intermediate dose cytarabine plus G-CSF compared to cyclophosphamide plus G-CSF in hematopoietic stem cell mobilization in patients with multiple myeloma
    Bogucka-Fedorczuk, Aleksandra
    Czyz, Anna
    Kalicinska, Elzbieta
    Sawicki, Mateusz
    Laszkowska-Lewko, Magdalena
    Wicherska-Pawlowska, Katarzyna
    Rybka, Justyna
    Szeremet, Agnieszka
    Prajs, Iwona
    Szymczak, Donata
    Wrobel, Tomasz
    JOURNAL OF CLINICAL APHERESIS, 2020, 35 (04) : 246 - 254
  • [27] Peripheral blood stem cell (PBSC) mobilization in breast cancer patients:: Chemotherapy plus G-CSF versus G-CSF alone
    Varo, MJ
    Azaceta, G
    Mayordomo, JI
    Tres, A
    Olave, T
    Moreno, JA
    Domingo, JM
    Gutiérrez, M
    Palomera, L
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 74 - 74
  • [28] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    Kaul, E.
    Shah, G.
    Chaulagain, C.
    Comenzo, R. L.
    BONE MARROW TRANSPLANTATION, 2014, 49 (09) : 1233 - 1233
  • [29] VERY HIGH EFFICACY OF CYTARABINE plus G-CSF COMPARED TO CYCLOPHOSPHAMIDE plus G-CSF AS HEMATOPOIETIC STEM CELL MOBILIZATION IN PATIENTS WITH LYMPHOID MALIGNANCIES REFERRED FOR AUTOLOGOUS TRANSPLANTATION
    Kruzel, T.
    Czerw, T.
    Sadus-Wojciechowska, M.
    Najda, J.
    Glowala-Kosinska, M.
    Chwieduk, A.
    Holowiecki, J.
    Giebel, S.
    ANNALS OF ONCOLOGY, 2012, 23 : 353 - 353
  • [30] Plerixafor and G-CSF for autologous stem cell mobilization in AL amyloidosis
    E Kaul
    G Shah
    C Chaulagain
    R L Comenzo
    Bone Marrow Transplantation, 2014, 49 : 1233 - 1233
12345